ARCA Biopharma CEO Richard B. Brewer: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Brewer speaks with the DAILY about ARCA’s genetically targeted Phase III beta blocker Gencaro and about the future of the company.